Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma
Clinical trial NCT07236528 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07236528
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-30
- Primary completion
- 2027-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.